Personalized prediction for a 82 year old man who takes Lyrica (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.


On Sep, 22, 2025, 624,368 related reports were analyzed:

What are the drugs?

What are the conditions?


Potential side effects:

Death
  • 8.84% for males aged 82 (±5) who take lyrica
Dizziness
  • 6.91% for males aged 82 (±5) who have diabetic neuropathy
Drowsiness
  • 6.45% for males aged 82 (±5) who have diabetic neuropathy
Drug ineffective
  • 11.98% for males aged 82 (±5) who have diabetic neuropathy
Fall
  • 6.91% for males aged 82 (±5) who have diabetic neuropathy
Fatigue
  • 5.22% for males aged 82 (±5) who have diabetic neuropathy
Hypotension
  • 5.07% for males aged 82 (±5) who have diabetic neuropathy
Insomnia
  • 5.84% for males aged 82 (±5) who have diabetic neuropathy
Pain
  • 9.83% for males aged 82 (±5) who have diabetic neuropathy
Pain in extremity
  • 5.68% for males aged 82 (±5) who have diabetic neuropathy
Weakness
  • 5.84% for males aged 82 (±5) who have diabetic neuropathy

Potential co-existing conditions:

Atrial fibrillation/flutter
  • 5.68% for males aged 82 (±5) who have diabetic neuropathy
  • 5.44% for males aged 82 (±5) who take lyrica
Cardiac disorder
  • 5.99% for males aged 82 (±5) who have diabetic neuropathy
Diabetes
  • 19.35% for males aged 82 (±5) who have diabetic neuropathy
Diabetic neuropathy
  • 100.0% for males aged 82 (±5) who have diabetic neuropathy
High blood cholesterol
  • 9.22% for males aged 82 (±5) who have diabetic neuropathy
High blood pressure
  • 18.59% for males aged 82 (±5) who have diabetic neuropathy
  • 6.23% for males aged 82 (±5) who take lyrica
Multiple myeloma
  • 5.86% for males aged 82 (±5) who take lyrica
Neuropathy peripheral
  • 16.44% for males aged 82 (±5) who have diabetic neuropathy
Pain in extremity
  • 5.07% for males aged 82 (±5) who have diabetic neuropathy
Type 2 diabetes
  • 13.67% for males aged 82 (±5) who have diabetic neuropathy

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe:

Recent personalized studies on eHealthMe: